These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 19699817)

  • 1. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier.
    Yuan Q; Shah J; Hein S; Misra RD
    Acta Biomater; 2010 Mar; 6(3):1140-8. PubMed ID: 19699817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assembled nanoparticles based on hydrophobically modified chitosan as carriers for doxorubicin.
    Zhang J; Chen XG; Li YY; Liu CS
    Nanomedicine; 2007 Dec; 3(4):258-65. PubMed ID: 17962086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of insulin nanoparticles using chitosan and its quaternized derivatives.
    Bayat A; Larijani B; Ahmadian S; Junginger HE; Rafiee-Tehrani M
    Nanomedicine; 2008 Jun; 4(2):115-20. PubMed ID: 18339584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quaternized chitosan-organic rectorite intercalated composites based nanoparticles for protein controlled release.
    Xu R; Xin S; Zhou X; Li W; Cao F; Feng X; Deng H
    Int J Pharm; 2012 Nov; 438(1-2):258-65. PubMed ID: 22982258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectorite-intercalated nanoparticles for improving controlled release of doxorubicin hydrochloride.
    Jin J; Tu H; Chen J; Cheng G; Shi X; Deng H; Li Z; Du Y
    Int J Biol Macromol; 2017 Aug; 101():815-822. PubMed ID: 28315438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chitosan-magnesium aluminum silicate nanocomposite films: physicochemical characterization and drug permeability.
    Khunawattanakul W; Puttipipatkhachorn S; Rades T; Pongjanyakul T
    Int J Pharm; 2010 Jun; 393(1-2):219-29. PubMed ID: 20398744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-polymer microparticles produced by supercritical assisted atomization.
    Reverchon E; Antonacci A
    Biotechnol Bioeng; 2007 Aug; 97(6):1626-37. PubMed ID: 17286274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan-TPP nanoparticle as a release system of antisense oligonucleotide in the oral environment.
    Dung TH; Lee SR; Han SD; Kim SJ; Ju YM; Kim MS; Yoo H
    J Nanosci Nanotechnol; 2007 Nov; 7(11):3695-9. PubMed ID: 18047039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chitosan nanoparticle as protein delivery carrier--systematic examination of fabrication conditions for efficient loading and release.
    Gan Q; Wang T
    Colloids Surf B Biointerfaces; 2007 Sep; 59(1):24-34. PubMed ID: 17555948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets.
    Khunawattanakul W; Puttipipatkhachorn S; Rades T; Pongjanyakul T
    Int J Pharm; 2011 Apr; 407(1-2):132-41. PubMed ID: 21291977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carboxymethyl chitosan-soy protein complex nanoparticles for the encapsulation and controlled release of vitamin D₃.
    Teng Z; Luo Y; Wang Q
    Food Chem; 2013 Nov; 141(1):524-32. PubMed ID: 23768389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Halloysite nanotubes for efficient loading, stabilization and controlled release of insulin.
    Massaro M; Cavallaro G; Colletti CG; D'Azzo G; Guernelli S; Lazzara G; Pieraccini S; Riela S
    J Colloid Interface Sci; 2018 Aug; 524():156-164. PubMed ID: 29649624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
    Yu JM; Li YJ; Qiu LY; Jin Y
    J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of zein nanoparticles coated with carboxymethyl chitosan for encapsulation and controlled release of vitamin D3.
    Luo Y; Teng Z; Wang Q
    J Agric Food Chem; 2012 Jan; 60(3):836-43. PubMed ID: 22224939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preparation and drug release property of paclitaxel nanoparticles].
    Wang TW; Wu Y; Li MJ; Gao HX
    Zhong Yao Cai; 2009 Sep; 32(9):1447-9. PubMed ID: 20034226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and characterization of chitosan/polyvinylpyrrolidone coated nanoporous γ-Alumina as a pH-sensitive carrier for controlled release of quercetin.
    Nematollahi E; Pourmadadi M; Yazdian F; Fatoorehchi H; Rashedi H; Nigjeh MN
    Int J Biol Macromol; 2021 Jul; 183():600-613. PubMed ID: 33932424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
    Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
    Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
    Mahmoud AA; El-Feky GS; Kamel R; Awad GE
    Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of porous aluminosilicate pellets for drug delivery.
    Byrne RS; Deasy PB
    J Microencapsul; 2005 Jun; 22(4):423-37. PubMed ID: 16214789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.